An experimental drug could help improve movement for patients with spinal cord injuries, and it's already making a big ...
NeuroSigma, Inc., a Los Angeles-based bioelectronics company, today announced a new publication in the journal Neuromodulation: Technology at the Neural Interface. The publication, titled "Oxygen-15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback